For research use only
| Cat No. | ABC-TC3791 |
| Product Type | Ocular Cells |
| Cell Type | Epithelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Retina |
| Disease | Normal |
| Storage | Liquid Nitrogen |
HRPE cells form pigmented monolayers, express RPE65/CRALBP, support retinal health, and are applied in AMD, RP, and Stargardt’s disease research.
Human Retinal Pigment Epithelial Cells (HRPECs) are primary epithelial cells isolated from the retina of healthy human donors via collagenase digestion. They constitute the monolayer known as the retinal pigment epithelium (RPE)—a specialized component of the human pigment epithelium—that forms the pigmented layer of the eye critical for retinal homeostasis. As a standard in vitro model of the native RPE, HRPECs are indispensable for studying RPE functions. These cells form a monolayer of polygonal cells rich in pigment granules and exhibit microvillous projections that interact with photoreceptor outer segments, supporting phagocytic function. HRPECs maintain the outer blood-retina barrier and are essential for retinal homeostasis, nutrient transport, and visual cycle processing. Dysfunction of HRPE integrity is implicated in retinal degenerative diseases such as age-related macular degeneration (AMD), retinitis pigmentosa (RP), and Stargardt’s disease. HRPECs express RPE65 and CRALBP, detected by immunocytochemistry or qPCR. Early passage HRPECs generally maintain a diploid karyotype and are not immortalized. They are tested negative for mycoplasma, bacteria, yeast, fungi, HIV-1, HIV-2, HTLV-I, and HTLV-II, ensuring biosafety compliance.
| Product Code | HRPEpiC |
| Species | Human |
| Cat.No | ABC-TC3791 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Retina |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Ocular Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Retinal Pigment Epithelial Cells (HRPECs) serve as a critical model for advancing ocular research and developing novel therapies for retinal diseases. These specialized cells enable in-depth investigation of retinal development, homeostasis, and disease mechanisms underlying conditions like age-related macular degeneration (AMD), retinitis pigmentosa, diabetic retinopathy, and photoreceptor degeneration. By studying HRPEC gene expression, cellular interactions, and dysfunction, researchers can identify biomarkers, test drug efficacy, and design targeted treatments—including cell-based therapies and gene editing approaches. Their application bridges fundamental research and clinical translation, offering potential breakthroughs in early diagnosis, disease modeling, and regenerative medicine for vision impairment.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Retinal Pigment Epithelial (RPE) Cells are specialized pigmented cells located in the outermost layer of the retina. They provide essential support to photoreceptors, facilitate nutrient transport, and play a crucial role in visual function by absorbing stray light and maintaining retinal health.
Dysfunction or degeneration of RPE cells is associated with several retinal diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa. Loss of RPE cell function can lead to photoreceptor death, resulting in vision loss.
These cells are extensively used in research focused on retinal diseases, photoreceptor biology, drug discovery, and tissue engineering. They are also integral to studies investigating the pathophysiology of AMD and the development of cell-based therapies for retinal degeneration.
Yes, RPE cells are widely researched for use in regenerative therapies, especially for treating diseases like AMD. Transplantation of healthy RPE cells into the retina holds promise for restoring function in damaged retinal tissues and preventing further vision loss.